Anthony O Caggiano

Cognition Therapeutics, Inc.

NIH Rank #221
  • Top 5% Funded
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$13.1M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#221
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $13.1M across 1 grant · National rank #221.

Top grants by award amount

Anthony O Caggiano's NIH grant portfolio, ranked by award amount.

  • 5R01AG065248-03R01
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    $13.1M
    award amount

Affiliation

Institutions that have administered grants for Anthony O Caggiano.

Affiliated with Cognition Therapeutics, Inc. (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Cognition Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #221
  8. 2024
    Entered Top 25% Nationally
    Ranked #221
  9. 2024
    Entered Top 10% Nationally
    Ranked #221
  10. 2024
    Entered Top 5% Nationally
    Ranked #221

Related investigators

Other NIH-funded PIs frequently associated with Anthony O Caggiano.